SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity
- Written by PR Newswire
 |
Growth of UK facility will enable clinical-grade manufacturing of drug substances for range of biopharmaceutical products
BURLINGTON, Mass., Nov. 15, 2024 /PRNewswire/ -- SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion at its UK site for...
